CS
Chandra Sekhar Rao Nagarouthu
About Chandra Sekhar Rao Nagarouthu
Data last updated:
Chandra Sekhar Rao Nagarouthu is a Director at Hethvik Pharmaceuticals Private Limited (since 2022). The company operates in Pharma. Hethvik Pharmaceuticals Private Limited reported revenue of ₹83.2 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Hethvik Pharmaceuticals Private Limited U24299TG2022PTC162468 | Director | 10 May 2022 | 2022 | ₹83.2 Lakh (FY 2025) | Active |
Board colleagues of Chandra Sekhar Rao Nagarouthu
| Name | DIN | Company | Designation |
|---|---|---|---|
| Bhavana Nagarouthu | 09600848 | Hethvik Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Chandra Sekhar Rao Nagarouthu
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Chandra Sekhar Rao Nagarouthu
Chandra Sekhar Rao Nagarouthu currently holds 1 directorship: Hethvik Pharmaceuticals Private Limited (Director, since 10 May 2022, revenue ₹83.2 Lakh (FY 2025)).
Chandra Sekhar Rao Nagarouthu was first appointed on 10 May 2022 as Director at Hethvik Pharmaceuticals Private Limited.
The current boards of Chandra Sekhar Rao Nagarouthu's companies include Bhavana Nagarouthu (Hethvik Pharmaceuticals Private Limited).